Breakthrough Trial Results Reveal Improved Overall Survival Benefit in Advanced Biliary Tract Cancer
MANILA – AstraZeneca, global, science-led biopharmaceutical company, announced the breakthrough results from the TOPAZ-1 Phase III trial, which showed that Durvalumab, in combination with standard-of-care chemotherapy, demonstrated a clinically meaningful and durable overall survival (OS) […]